Literature DB >> 15862707

Mechanism of the tumor suppressive effect of MnSOD overexpression.

Larry W Oberley1.   

Abstract

The mitochondrial antioxidant protein manganese-containing superoxide dismutase (MnSOD) has been shown to be a new type of tumor suppressor protein. Overexpression of MnSOD protein inhibits growth in a wide variety of cancer types. This review examines the molecular mechanism of the tumor suppressive effect of MnSOD. Three species have been proposed to cause the tumor suppressive effect: superoxide radical, hydrogen peroxide and nitric oxide. At the present time, the evidence appears strongest that hydrogen peroxide is the effector molecule since both catalase and glutathione peroxidase has been shown to modulate the effect. Surprisingly, in different cancer cell lines, overexpression of GPx has been found to both decrease and increase the growth inhibitory effect of MnSOD overexpression. Knowledge of which molecule causes the tumor suppressive effect of MnSOD and the mechanism of action will likely lead to new therapies for the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862707     DOI: 10.1016/j.biopha.2005.03.006

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  84 in total

Review 1.  Manganese superoxide dismutase: beyond life and death.

Authors:  Aaron K Holley; Sanjit Kumar Dhar; Yong Xu; Daret K St Clair
Journal:  Amino Acids       Date:  2010-05-08       Impact factor: 3.520

2.  Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress.

Authors:  Randa Tao; Mitchell C Coleman; J Daniel Pennington; Ozkan Ozden; Seong-Hoon Park; Haiyan Jiang; Hyun-Seok Kim; Charles Robb Flynn; Salisha Hill; W Hayes McDonald; Alicia K Olivier; Douglas R Spitz; David Gius
Journal:  Mol Cell       Date:  2010-12-22       Impact factor: 17.970

Review 3.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

4.  Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer.

Authors:  John A Cieslak; Robert K Strother; Malvika Rawal; Juan Du; Claire M Doskey; Samuel R Schroeder; Anna Button; Brett A Wagner; Garry R Buettner; Joseph J Cullen
Journal:  Free Radic Biol Med       Date:  2015-02-26       Impact factor: 7.376

Review 5.  Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence.

Authors:  Sarah Crawford
Journal:  Ther Adv Med Oncol       Date:  2014-03       Impact factor: 8.168

6.  Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells.

Authors:  Yong Xu; Fang Fang; Sanjit K Dhar; Antonio Bosch; William H St Clair; Edward J Kasarskis; Daret K St Clair
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

Review 7.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

8.  A role for mitochondrial dysfunction in perpetuating radiation-induced genomic instability.

Authors:  Grace J Kim; Gary M Fiskum; William F Morgan
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

Review 9.  MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx.

Authors:  Demet Candas; Jian Jian Li
Journal:  Antioxid Redox Signal       Date:  2013-06-08       Impact factor: 8.401

10.  Mitochondrial manganese superoxide dismutase mRNA expression in human chorioamniotic membranes and its association with labor, inflammation, and infection.

Authors:  Nandor Gabor Than; Roberto Romero; Adi L Tarca; Sorin Draghici; Offer Erez; Tinnakorn Chaiworapongsa; Yeon Mee Kim; Sun Kwon Kim; Edi Vaisbuch; Gerard Tromp
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.